APA
ESPR

American Portfolios Advisors’s Esperion Therapeutics ESPR Stock Holding History

American Portfolios Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$311K Buy
46,490
+3,540
+8% +$24.3K 0.01% 837
2022
Q2 		$273K Hold
42,950
– – 0.01% 912
2022
Q1 		$199K Buy
42,950
+235
+0.6% +$1.01K 0.01% 1160
2021
Q4 		$214K Buy
42,715
+13,155
+45% +$105K 0.01% 1129
2021
Q3 		$356K Buy
29,560
+1,125
+4% +$16.4K 0.01% 865
2021
Q2 		$601K Buy
28,435
+3,375
+13% +$81.3K 0.02% 632
2021
Q1 		$703K Buy
25,060
+2,875
+13% +$84.8K 0.03% 533
2020
Q4 		$577K Buy
22,185
+1,290
+6% +$38.6K 0.03% 515
2020
Q3 		$777K Buy
20,895
+6,140
+42% +$243K 0.04% 363
2020
Q2 		$757K Buy
14,755
+2,910
+25% +$122K 0.05% 337
2020
Q1 		$373K Buy
11,845
+7,425
+168% +$392K 0.03% 443
2019
Q4 		$264K Buy
4,420
+200
+5% +$8.99K 0.02% 641
2019
Q3 		$155K Buy
4,220
+200
+5% +$7.92K 0.01% 802
2019
Q2 		$187K Sell
4,020
-300
-7% -$14.1K 0.02% 735
2019
Q1 		$173K Buy
4,320
+475
+12% +$21.3K 0.02% 688
2018
Q4 		$177K Hold
3,845
– – 0.02% 551
2018
Q3 		$171K Buy
3,845
+700
+22% +$32.1K 0.02% 641
2018
Q2 		$123K Sell
3,145
-2,330
-43% -$118K 0.02% 728
2018
Q1 		$396K Hold
5,475
– – 0.06% 318
2017
Q4 		$360K Buy
+5,475
New +$295K 0.06% 333

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

American Portfolios Advisors's ESPR Position: Q3 2022 in Review

American Portfolios Advisors increased its Esperion Therapeutics (ESPR) stake by 8.2% in Q3 2022, buying an estimated $24.3K and bringing the position to 46,490 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #837.

American Portfolios Advisors first reported a position in ESPR in Q4 2017 and has held it in 20 quarters since. The position peaked at $777K in Q3 2020. 148 funds tracked by Wall St. Rank hold ESPR as of Q3 2022.

  • American Portfolios Advisors held 46,490 shares of Esperion Therapeutics worth $311K as of Q3 2022.
  • American Portfolios Advisors bought 3,540 Esperion Therapeutics shares in Q3 2022, an estimated $24.3K.
  • Esperion Therapeutics made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #837 holding.
  • American Portfolios Advisors first reported a position in Esperion Therapeutics in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Esperion Therapeutics position peaked at $777K in Q3 2020.
  • 148 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.